SCHEMBL6586916

SCHEMBL6586916

Cc1ccc2ccc(CCl)nc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.56
NPSR1 Q6W5P4 1/20 0.56
CYP1A2 P05177 4/20 0.55
ALDH1A1 P00352 7/20 0.46
ESR1 P03372 1/20 0.42
CYP2A6 P11509 3/20 0.41
NQO2 P16083 1/20 0.41
KDM4E B2RXH2 3/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
PABPC1 P11940 1/20 0.40
HSD17B10 Q99714 1/20 0.39
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NCK1 P16333 1/20 0.37
BACE1 P56817 1/20 0.37
TDP1 Q9NUW8 2/20 0.37
GAA P10253 2/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1724199 0.86 CYP1A2 (0.57) KMT2ANPSR1CYP1A2ALDH1A1CYP2A6
SCHEMBL16284370 0.82 CYP1A2 (0.57) KMT2ANPSR1CYP1A2ALDH1A1ESR1
SCHEMBL8181929 0.80 KMT2A (0.43) KMT2ANPSR1CYP1A2ALDH1A1NQO2
SCHEMBL202431 0.80 CYP1A2 (0.55) KMT2ANPSR1CYP1A2ALDH1A1ESR1
SCHEMBL3276372 0.78 NR4A2 (0.47) KMT2ANPSR1CYP1A2CYP2A6MAPT
SCHEMBL9757427 0.77 MAPT (0.42) KMT2ANPSR1ALDH1A1MEN1MAPT
SCHEMBL19067629 0.77 CYP1A2 (0.52) KMT2ANPSR1CYP1A2ALDH1A1ESR1
SCHEMBL6584464 0.76 BACE1 (0.52) KMT2ANPSR1CYP1A2ALDH1A1CYP2A6
SCHEMBL5208223 0.76 PDE10A (0.42) KMT2ACYP1A2CYP2A6KDM4EBACE1
SCHEMBL8185499 0.76 ALDH1A1 (0.59) KMT2ACYP1A2ALDH1A1CYP2A6NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0784052-B1 Quinoline derivatives as antagonists of leukotriene d4, compositions containing the same and processes for their preparation AVENTIS HOLDINGS INC (US) 2004-09-01 EP disclosed
EP-0643045-B1 Quinoline derivatives as leukotriene antagonists NOVARTIS AG (CH) 2000-03-08 EP disclosed
EP-0784052-A1 Quinoline derivatives as antagonists of leukotriene d4, compositions containing the same and processes for their preparation RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1997-07-16 EP disclosed
US-5508408-A LEUKOTRIENE ANTAGONISTS CIBA-GEIGY CORPORATION (US) 1996-04-16 US disclosed
EP-0643045-A1 Quinoline derivatives as leukoriene antagonists CIBA-GEIGY AG (CH) 1995-03-15 EP disclosed
EP-0434827-A4 QUINOLINYL-BENZOPYRAN DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4? 1992-01-08 EP disclosed
EP-0434827-A1 QUINOLINYL-BENZOPYRAN DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4? RORER INTERNATIONAL (HOLDINGS), INC. (US) 1991-07-03 EP disclosed
WO-1991001123-A2 QUINOLINYL-BENZOPYRAN DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D¿4? RORER INTERNATIONAL (OVERSEAS) INC. (US) 1991-02-07 WO disclosed
US-4977162-A Quinolinyl-chromone derivatives and use for treatment of hypersensitive ailments RORER PHARMACEUTICAL CORPORATION (US) 1990-12-11 US disclosed
US-4920131-A Quinoline derivatives and use thereof as antagonists of leukotriene D4 RORER PHARMACEUTICAL CORP. (US) 1990-04-24 US disclosed
EP-0348155-A1 Quinoline derivatives as antagonists of leukotriene D4, compositions containing the same and processes for their preparation RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1989-12-27 EP disclosed